Centers for Medicare & Medicaid Services

105 articles with Centers for Medicare & Medicaid Services

• Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics

  1/13/2021

  The Centers for Medicaid & Medicare (CMS) announced the establishment of the Medicare Coverage of Innovative Technology (MCIT) pathway ( RIN: 0938-AT88 ), to provide a coverage pathway for Medicare beneficiaries nationwide to have faster access to new, innovative medical devices and diagnostic tests designated under the Breakthrough Device review program and with market authorization by the U.S. Food and Drug Administration (FDA). Under MCIT, na

• Vizient Urges Delay of Most Favored Nation Model for Physician-Administered Drugs

  12/11/2020

  Vizient, Inc. called for the Centers for Medicare and Medicaid Services to delay the start of the recently finalized Most Favored Nation Model for certain physician-administered drugs.

• Itamar Medical Comments on U.S. Centers for Medicare & Medicaid Services (CMS) 2021 Fee Schedule with Reimbursement Update for Home Sleep Apnea Testing

  12/9/2020

  WatchPAT™ to effectively maintain current reimbursement levels despite broader reduction in conversion rates

• CMS grants transitional pass-through (TPT) payment for Stryker's SpineJack® System

  12/4/2020

  -The Centers for Medicare &; Medicaid Services (CMS) announced the SpineJack implantable fracture reduction system qualified for the Transitional Pass-Through (TPT) payment as part of the 2021 Medicare Hospital Outpatient Prospective Payment System.

• Medically Home Ready to Enable Nationwide Scale-up of High-Acuity Home Hospitalization

  11/25/2020

  Responding to 's action by the Centers for Medicare & Medicaid Services to accelerate hospital-at-home programs, Medically Home Group said it is prepared to enable health systems nationwide to establish and rapidly expand high-acuity home hospitalization programs.

• General Dynamics Information Technology Awarded $241 Million Multi-Cloud Contract by Centers for Medicare and Medicaid Services

  11/25/2020

  General Dynamics Information Technology, a business unit of General Dynamics, announced it has been awarded a new contract by the Department of Health and Human Services Centers for Medicare and Medicaid Services to provide cloud services and software tools.

• Health Net Earns High Marks in CMS 2021 Star Ratings Report

  11/23/2020

  Health Net announced its Medicare Advantage plans in California earned high marks from the Centers for Medicare & Medicaid Services in the annual Star Quality Ratings for rating year 2021.

• Biocom California Stands Firm Against Most Favored Nation Rule

  11/21/2020

  Biocom California, the association representing the California life science industry, issued the following statement in response to the release of the Most Favored Nation Model by the Centers for Medicare and Medicaid Services.

• Centers for Medicare & Medicaid Services (CMS) Issues Permanent J-Code for UroGen’s Jelmyto® Effective January 1, 2021

  11/11/2020

  UroGen Pharma Ltd. announced that the Centers for Medicare & Medicaid Services has established a permanent and product-specific J-code for Jelmyto® for pyelocalyceal solution that will take effect on January 1, 2021.

• InControl Medical, LLC Certified as Medicare Provider

  11/9/2020

  InControl Medical, LLC announced that the Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human Services has authorized the Company to be a Medicare Provider.

• More than 4 out of 5 Aetna Medicare members in 4 Star-rated plans or higher for 2021

  10/28/2020

  For the seventh consecutive year, Aetna®, a CVS Health® company, announced its 2021 Medicare Advantage Prescription Drug plans outpace the Medicare Advantage industry in the percentage of members in plans rated 4 stars or higher by the Centers for Medicare & Medicaid Services.

• IPRO to Provide Hospital Quality Improvement Services for the Centers for Medicare & Medicaid Services

  10/19/2020

  The Centers for Medicare & Medicaid Services has awarded a four-year contract to IPRO to serve as a Hospital Quality Improvement Contractor within its Network of Quality Improvement and Innovation Contractors.

• AAOS Registry Program Partners with CMS on Bundled Payment Model

  10/8/2020

  Data reported through AAOS Registries now qualifies for new Alternate Quality Measures Set

• Vizient Offers Comments to CMS on the OPPS and Physician Fee Schedule Proposed Rules

  10/6/2020

  Vizient, Inc. submitted comments to the Centers for Medicare & Medicaid Services yesterday on two key Medicare regulatory proposals – the Calendar Year 2021 Outpatient Prospective Payment System and the CY 2021 Physician Fee Schedule and Quality Payment Program.

• Hemospray® Now Eligible for Additional Medicare Reimbursement to Help Reduce Financial Barriers to Patient Care

  10/6/2020

  Cook Medical announced that the U.S. Centers for Medicare and Medicaid Services has granted a new technology add-on payment for Hemospray® Endoscopic Hemostat.

• AAOS Comments on Proposed Medicare Payment Policy Changes for 2021

  10/5/2020

  The American Association of Orthopaedic Surgeons issued formal comments to the Centers for Medicare & Medicaid Services on the agency's proposed payment policy changes for Calendar Year 2021.

• CMS Now Requires Health Care Workers to Receive Access to Long Term Care Facility Patients to Improve Resident Outcomes, Reports the Polaris Group

  9/22/2020

  The Centers for Medicare & Medicaid Services released a memorandum on Thursday, September 17 that requires Nursing Homes to permit access to health care workers who are not employees of the facility if they meet certain screening requirements.

• T2 Biosystems Announces CMS Approval of a New Technology Add-On Payment for the T2Bacteria® Panel for a Second YearPayment Covers 65 Percent of the Average Cost of the Test Panel for Eligible Patients

  9/4/2020

  T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens, announced that the U.S. Centers for Medicare & Medicaid Services continued the New Technology Add-on Payment for the Company’s T2Bacteria® Panel for Fiscal Year 2021.

• Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS

  9/3/2020

  Shionogi Granted New Technology Add-on Payment For FETROJA ® (Cefiderocol) by CMS Add-on Payment to Reimburse Hospitals up to 75 percent of the cost of FETROJA in Hospital Inpatient Setting OSAKA, Japan and FLORHAM PARK, N.J.--( BUSINESS WIRE )-- Shionogi & Co., Ltd. (hereafter “Shionogi”) today announces that the Centers for Medicare & Medicaid Services (CMS) has granted a new technology add-on payment (NTAP) for FETROJA ® (cefiderocol) whe

• Baudax Bio Secures Permanent J-Code (J1738) for ANJESO® from Centers for Medicare and Medicaid Services

  8/6/2020

  Baudax Bio, Inc., a pharmaceutical company focused on therapeutics for acute care settings, announced that the Centers for Medicare and Medicaid Services established a new permanent J-code for ANJESO injection facilitating reimbursement in the hospital outpatient, ambulatory surgery center and physician office settings of care.